Group One Trading’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-33,812
Closed -$70.1K 8392
2023
Q1
$85.9K Sell
33,812
-6,078
-15% -$12K ﹤0.01% 4431
2022
Q4
$74.6K Sell
39,890
-63,078
-61% -$157K ﹤0.01% 4693
2022
Q3
$265K Buy
102,968
+57,058
+124% +$142K ﹤0.01% 3876
2022
Q2
$89K Buy
45,910
+45,510
+11,378% +$99.3K ﹤0.01% 5095
2022
Q1
$1K Sell
400
-9,737
-96% -$36.6K ﹤0.01% 7914
2021
Q4
$46K Sell
10,137
-4,179
-29% -$19.8K ﹤0.01% 6409
2021
Q3
$70K Sell
14,316
-40,705
-74% -$224K ﹤0.01% 6266
2021
Q2
$375K Buy
55,021
+36,201
+192% +$293K ﹤0.01% 4539
2021
Q1
$133K Sell
18,820
-122,082
-87% -$879K ﹤0.01% 5400
2020
Q4
$882K Buy
140,902
+56,586
+67% +$333K ﹤0.01% 2762
2020
Q3
$456K Buy
84,316
+64,351
+322% +$319K ﹤0.01% 2924
2020
Q2
$104K Sell
19,965
-393
-2% -$1.75K ﹤0.01% 3882
2020
Q1
$64K Sell
20,358
-3,595
-15% -$13.3K ﹤0.01% 3573
2019
Q4
$97K Buy
23,953
+13,633
+132% +$47.3K ﹤0.01% 3660
2019
Q3
$45K Buy
10,320
+8,438
+448% +$33.7K ﹤0.01% 4026
2019
Q2
$8K Buy
+1,882
New +$8.95K ﹤0.01% 4504
2018
Q1
Sell
-15,987
Closed -$238K 5432
2017
Q4
$286K Sell
15,987
-12,445
-44% -$260K ﹤0.01% 2680
2017
Q3
$714K Buy
28,432
+28,137
+9,538% +$655K 0.01% 1810
2017
Q2
$7K Buy
+295
New +$6.52K ﹤0.01% 4340
2014
Q2
Sell
-302
Closed -$9.85K 5577
2014
Q1
$11K Buy
+302
New +$11.9K ﹤0.01% 4543
2013
Q3
Sell
-1,510
Closed -$54.1K 5688
2013
Q2
$55K Buy
+1,510
New +$64.7K ﹤0.01% 3361

Group One Trading's PRTK Position: Q2 2023 in Review

Group One Trading sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q2 2023, closing a stake of 33,812 shares — an estimated $70.1K sold.

Group One Trading first reported a position in PRTK in Q2 2013 and held it in 21 quarters. The position peaked at $882K in Q4 2020. 66 funds tracked by Wall St. Rank hold PRTK as of Q2 2023.

  • Group One Trading reported no remaining Paratek Pharmaceuticals, Inc. position as of Q2 2023 after selling out during the quarter.
  • Group One Trading sold 33,812 Paratek Pharmaceuticals, Inc. shares in Q2 2023, an estimated $70.1K.
  • Group One Trading first reported a position in Paratek Pharmaceuticals, Inc. in Q2 2013 and held it in 21 quarters.
  • Group One Trading's Paratek Pharmaceuticals, Inc. position peaked at $882K in Q4 2020.
  • 66 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q2 2023.

Based on Group One Trading's 13F filing for Q2 2023, filed 9 Aug 2023.